5[1]Scandinavian simvastatin survival study group. random ised trial of cholesterol lowering in 4444 patients with coronay heart disease:the Scandinavian simvastatin snrvival study(4s), lanceti 1994: 344:1383～1389.
6[2]Sack FM, Pfeffer MA, Moye LA, et al, The effect ofpravastatin on coronay events after myocardial infarction in Patients with average cholisterol levels, N Engl J Med 1996 ; 335:1001 ～ 1009.
7[3]The Long-Term intervention with pravastatin in ischaemic disease (Li-pid) study Group. Prevention of cardiovasculer events and death with pvavastatin in patients with coronary heart disease and a broad Range of initialcholesterol levels. N Engl J med 1998: 339:1345～ 1357
8[4]Grndy SM. Consensus statement: role of therapy with" statin" in patients with hypertriglyceridemia (J). Am JCanliol, 1998,81 (suppl 4A): 1B～ 6B.
9[5]Marais AD, Naoumova RP, Firth JC, Pennyc, et al.Decreased production of low density tinomorein by at al, Decreased production of lou density lipoprotein by atorvastatin after apheresis in homozygous familialhvpercholeoterolemia, J lipid Res, 1997,38: 2071～2078
10[7]Treasnre CB, Klein JL, Weintraub WS, et al. Beneticial effects of cholesterol lowering therapy on the coronaryendothelium in patients wth coronary artery disease. NEng J Med, 1995,332:481～487
